Sharp Therapeutics Corp. (SHRX.V)
2.25
0.00 (0.00%)
CAD |
TSXV |
Mar 27, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 67.67M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 20.97% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Sharp Therapeutics Corp. operates as a biology technology company, which engages in research and development of therapeutic treatment for genetic diseases. It offers CoreX biology, AlloChem chemistry, and a mine data system. The company was founded on October 4, 2021 and is headquartered in Pittsburgh, PA. |
| URL | http://www.sharptx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Pennsylvania |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Sharp Therapeutics Corp. operates as a biology technology company, which engages in research and development of therapeutic treatment for genetic diseases. It offers CoreX biology, AlloChem chemistry, and a mine data system. The company was founded on October 4, 2021 and is headquartered in Pittsburgh, PA. |
| URL | http://www.sharptx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Pennsylvania |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |